Megan Bailey is listed as an executive officer and director on 2 SEC Form D filings by 1 issuer between May 2020 and Feb 2021: Personal Genome Diagnostics Inc. (Baltimore, MD — biotechnology — 2020–2021; $97.7M reported sold to 38 investors).
What this means One deal on file with the SEC. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside Jack Crowley (2 shared filings), James LaFrance (2 shared filings), Justin Klein (2 shared filings), Kavita Patel (2 shared filings), Luis A. Diaz, Jr. (2 shared filings) and 8 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Megan. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, OK, OR, PA, RI, SC, SD, TN, TX, VT, WA, WI, WV, WY) — 5 bankruptcy cases matching the name listed in Key records below.
What this means 5 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 2 public filings for Megan Bailey and found 6 differences: Bankruptcy case: Garry A. Nicholson and Bobbie A. Nicholson; Form D filed 18 days after the first sale; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.